Examkin

Question

Difficulty: HardClinical Preventive Services and Screening

A 15-month-old girl is brought to the clinic for a delayed well-child visit. Her parents report she missed her 12-month appointment due to scheduling conflicts. Her past medical history is significant for severe persistent asthma. Three weeks ago, she was hospitalized for a severe asthma exacerbation and was discharged on a 4-week taper of oral prednisone, initially at 22 mg/kg/day. She is currently on day 21 of the taper, taking 1.51.5 mg/kg/day. Environmental history reveals no household exposure to secondhand smoke (0 pack-years). Family history is notable for asthma in her mother and colon cancer in her paternal grandfather. Current vital signs are temperature 37.1°C (98.8°F), pulse 110/min, and respirations 24/min. Physical examination shows an active, well-appearing child with clear lungs. Her immunization record indicates she received all recommended doses at her 2-, 4-, and 6-month visits. In addition to catch-up doses of Haemophilus influenzae type b (Hib) and pneumococcal conjugate vaccines, which of the following is the most appropriate next step regarding this patient's routine immunizations?

  1. Administer the inactivated influenza vaccine today and defer the measles, mumps, and rubella (MMR) and varicella vaccinesAnswer
  2. B
    Administer the measles, mumps, and rubella (MMR) vaccine, varicella vaccine, and inactivated influenza vaccine today
  3. C
    Administer the live-attenuated intranasal influenza vaccine today and defer the MMR and varicella vaccines
  4. D
    Administer the varicella vaccine today but defer the MMR vaccine until the prednisone taper is completed
  5. E
    Administer the oral rotavirus vaccine and MMR vaccine today

Answer

The most appropriate action is to administer the inactivated influenza vaccine today and defer live-attenuated vaccines (MMR and varicella) until the immune system recovers.
This patient is currently receiving high-dose systemic corticosteroids, defined as a daily dose of ≥2\geq 2 mg/kg or ≥20\geq 20 mg of prednisone (or equivalent) for ≥14\geq 14 consecutive days. This prolonged regimen causes significant iatrogenic cellular immunosuppression. In such immunocompromised states, the administration of live-attenuated vaccines can lead to unchecked viral replication and severe, potentially fatal vaccine-strain infections. Therefore, live vaccines normally scheduled at 12 to 15 months, including the measles, mumps, and rubella (MMR) and varicella vaccines, must be deferred until the immune system recovers (typically at least one month after discontinuing the high-dose steroids). However, inactivated vaccines, such as the injectable formulation of the influenza vaccine, pose no risk of systemic infection and should be administered according to the normal catch-up schedule.

Step-by-Step Solution

1
Identify the patient's current medication status and its immunological effect.
The patient is on day 21 of a corticosteroid taper that began at 22 mg/kg/day.
High-dose systemic corticosteroids (≥2\geq 2 mg/kg/day or ≥20\geq 20 mg/day of prednisone for ≥14\geq 14 days) cause profound iatrogenic cellular immunosuppression.
2
Determine the patient's immunization needs.
The patient is missing her 12-month routine vaccines, which classically include the live-attenuated MMR and varicella vaccines, as well as seasonal influenza.
To provide necessary preventive care without causing harm.
3
Apply general immunization guidelines for immunocompromised hosts.
Live-attenuated vaccines must be deferred, while inactivated vaccines are safe to administer.
Live vaccines can cause disseminated vaccine-strain infection in patients lacking sufficient cellular immunity.

Key Concept

Administration of live-attenuated vaccines is strictly contraindicated in patients receiving high-dose systemic corticosteroids due to the risk of unchecked viral replication.
Rate this question

Topics

Clinical Preventive Services and Screening

More questions from this topic